For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its 2025 Power 100 list, which can be found here. 

Pennsylvania State Sen. Steve Santarsiero of Bucks County, a strong supporter of the three nonprofits that Kassa leads, said, “It is no surprise that Lou continues to get attention for his growing influential role in the nation’s biotech industry by promoting the exceptional nonprofit model of nurturing independent research into viable commercial ventures that improve health outcomes.” 

The magazine notes that this past October, the state of New York selected Doylestown’s Baruch S. Blumberg Institute, the operator of the biotech center, to manage a life sciences incubator that will be part of a planned $430 million cell and gene therapy campus in Long Island, which Lou has led.